Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
about
Psoriasis registries worldwide: systematic overview on registry publications.Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasisPhoto(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisPatient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference?[Phototherapy in the era of biologicals].Phototherapy in France: quantitative data from the National Health Insurance register.Bath vs. oral psoralen plus ultraviolet A: is one more effective than the other?Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.An observational, prospective study of monthly adalimumab therapy for disease maintenance in psoriasis patients: a possible new therapeutic option for good responders to the initial induction treatment.The Prevalence of Periodontitis Is Increased in Psoriasis and Linked to Its Inverse Subtype.Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.Updates from the British Association of Dermatologists 91st annual meeting, 5-7 July 2011, London, U.K.British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.
P2860
Q30251454-130507C9-45B8-4FDC-8B0A-6D698BD0F011Q34294189-481EBCE8-CFDF-4DAA-8C26-1E0FDA75F4CEQ34555643-8148B4AF-6251-4292-91A1-FE06FC65F2BAQ34568403-EDB60B30-5C09-4451-9316-91AB75957083Q35005664-6DF58308-3DEE-4940-BC8B-0BA2E59A2FE4Q37053020-A0A39B8D-5FED-46E7-8E37-7A6FBE2D963FQ37724124-7ADA2705-16E0-4ADA-8199-4FEA0DB9CD37Q40380596-8C1CAF1E-AF87-44BC-9677-51A26E508413Q40626002-2952509A-FFC4-4A1C-961A-B0F8EC7E85D7Q43872006-DE90FF44-7DE1-458B-AA4A-EEE80717342BQ43916014-79278B82-DD79-4000-B2FA-F9D56856BCCBQ44642340-83BF2E3D-B34F-422C-BC74-BBDFCE011244Q45839560-F74F7DB6-7F58-4AC0-933B-93ACF0570169Q46609215-B99E4063-9416-46FB-9A90-D3C8FF95E5B4Q47608847-A76C534D-6DCC-43CE-B39B-E37988B8FE65Q48368354-5DAF3C98-AC21-47EF-A3CA-6564B3E07D5CQ50973080-6136C2A5-0EC1-48C0-BEED-271294B4507BQ51189512-FEA458B8-B359-4029-99CD-69668F533256Q52818545-32EEF0C0-0A52-4850-B52B-73F6C46FEEF2
P2860
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@ast
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@en
type
label
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@ast
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@en
prefLabel
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@ast
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@en
P2093
P2860
P1476
Efficacy of psoralen plus ultr ...... nalysis of a patient registry.
@en
P2093
A Gruber-Wackernagel
F Quehenberger
M Inzinger
W Salmhofer
P2860
P304
P356
10.1111/J.1365-2133.2011.10396.X
P407
P577
2011-07-11T00:00:00Z